Site identity card

Federico II University Hospital

Naples, Italy
Share

Networks

Clinical Studies (2)

  • Pinchera : Study aims to evaluate the risk of breakthrough infection, symptomatic disease, hospitalisation, intensive care admission, and COVID-19 related death in kidney transplant recipients receiving pre-exposure prophylaxis with Tixagevimab/Cilgavimab for COVID-19 in the era of the Kraken variant
  • Gentile : Study aims to determine the efficacy and safety of a combination of two antivirals, with and without a monoclonal antibody, in both the early and later phases of SARS-CoV-2 infection in immunocompromised patients

Study Data

  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Infectious diseases unit
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to